- Home
- BNR vs OKYO Comparison
BNR vs OKYO Comparison
Compare BNR & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- OKYO
- Stock Information
- Founded
- BNR 2014
- OKYO 2007
- Country
- BNR China
- OKYO United Kingdom
- Employees
- BNR N/A
- OKYO N/A
- Industry
- BNR Medical Specialities
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BNR Health Care
- OKYO Health Care
- Exchange
- BNR Nasdaq
- OKYO Nasdaq
- Market Cap
- BNR 30.9M
- OKYO 37.0M
- IPO Year
- BNR 2020
- OKYO 2022
- Fundamental
- Price
- BNR $2.84
- OKYO $1.51
- Analyst Decision
- BNR
- OKYO Strong Buy
- Analyst Count
- BNR 0
- OKYO 1
- Target Price
- BNR N/A
- OKYO $7.00
- AVG Volume (30 Days)
- BNR 17.2K
- OKYO 49.5K
- Earning Date
- BNR 05-28-2025
- OKYO 05-06-2025
- Dividend Yield
- BNR N/A
- OKYO N/A
- EPS Growth
- BNR N/A
- OKYO N/A
- EPS
- BNR N/A
- OKYO N/A
- Revenue
- BNR $70,669,261.00
- OKYO N/A
- Revenue This Year
- BNR $136.32
- OKYO N/A
- Revenue Next Year
- BNR N/A
- OKYO N/A
- P/E Ratio
- BNR N/A
- OKYO N/A
- Revenue Growth
- BNR N/A
- OKYO N/A
- 52 Week Low
- BNR $2.62
- OKYO $0.81
- 52 Week High
- BNR $8.99
- OKYO $1.74
- Technical
- Relative Strength Index (RSI)
- BNR 23.18
- OKYO 66.28
- Support Level
- BNR $2.77
- OKYO $1.03
- Resistance Level
- BNR $3.48
- OKYO $1.71
- Average True Range (ATR)
- BNR 0.35
- OKYO 0.11
- MACD
- BNR 0.04
- OKYO 0.05
- Stochastic Oscillator
- BNR 5.93
- OKYO 70.59
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.